Bryan C. Hanson - 06 Mar 2023 Form 4 Insider Report for ZIMMER BIOMET HOLDINGS, INC. (ZBH)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
08 Mar 2023, 15:27:42 UTC
Prior SEC filing
23 Feb 2023
Next SEC filing
06 Sep 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Matthew R. St. Louis, Attorney-in-Fact for Bryan C. Hanson (power of attorney previously filed)

Key filing fact

Bryan C. Hanson filed Form 4 for ZIMMER BIOMET HOLDINGS, INC. (ZBH) on 08 Mar 2023.

Key facts

  • This page summarizes Bryan C. Hanson's Form 4 filing for ZIMMER BIOMET HOLDINGS, INC. (ZBH).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 08 Mar 2023, 15:27.

Change

  • Previous filing in this sequence was filed on 23 Feb 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ZBH transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+47,625
Change %
Price
$0.000000
Shares after
47,625
Date
06 Mar 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
47,625
Exercise price
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

Footnote F2

Vests annually over three years in increments of one-third each year, commencing March 6, 2024.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .